These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 38492738)

  • 1. Women's acceptance of two strategies for preventing respiratory syncytial virus infant bronchiolitis: maternal immunization or monoclonal antibodies for newborns.
    Roblin A; Lachâtre M; Charlier C; Launay O; Tsatsaris V; Anselem O
    Clin Microbiol Infect; 2024 Jul; 30(7):958-960. PubMed ID: 38492738
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prevention of respiratory syncytial virus bronchiolitis].
    Marchac V
    Arch Pediatr; 2006 Dec; 13 Suppl 5():S12-7. PubMed ID: 17550819
    [No Abstract]   [Full Text] [Related]  

  • 3. Bovine model of respiratory syncytial virus infection.
    Taylor G
    Curr Top Microbiol Immunol; 2013; 372():327-45. PubMed ID: 24362697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Passive Immunization Strategies to Prevent Severe Respiratory Syncytial Virus Infection Among Newborns and Young Infants.
    Suryadevara M
    J Pediatric Infect Dis Soc; 2024 Jul; 13(Supplement_2):S110-S114. PubMed ID: 38995085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A safe and efficient BCG vectored vaccine to prevent the disease caused by the human Respiratory Syncytial Virus.
    Rey-Jurado E; Soto J; Gálvez N; Kalergis AM
    Hum Vaccin Immunother; 2017 Sep; 13(9):2092-2097. PubMed ID: 28598702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection of neonates and infants by maternal immunization.
    Gerdts V; van Drunen Littel-van den Hurk S; Potter A
    Expert Rev Vaccines; 2016 Nov; 15(11):1347-1349. PubMed ID: 27248694
    [No Abstract]   [Full Text] [Related]  

  • 7. Prevention of Pediatric Respiratory Syncytial Virus Lower Respiratory Tract Illness: Perspectives for the Next Decade.
    Aranda SS; Polack FP
    Front Immunol; 2019; 10():1006. PubMed ID: 31134078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Respiratory syncytial virus].
    Seidenberg J
    Internist (Berl); 2019 Nov; 60(11):1146-1150. PubMed ID: 31486858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigational RSV Vaccine Given During Pregnancy Protects Newborns.
    Larkin H
    JAMA; 2022 Dec; 328(22):2201. PubMed ID: 36511938
    [No Abstract]   [Full Text] [Related]  

  • 10. Prevention of bronchiolitis.
    Pringle CR
    Paediatr Respir Rev; 2000 Sep; 1(3):228-34. PubMed ID: 12531084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Randomized, Controlled, Observer-Blinded Phase 1 Study of the Safety and Immunogenicity of a Respiratory Syncytial Virus Vaccine With or Without Alum Adjuvant.
    Langley JM; Aggarwal N; Toma A; Halperin SA; McNeil SA; Fissette L; Dewé W; Leyssen M; Toussaint JF; Dieussaert I
    J Infect Dis; 2017 Jan; 215(1):24-33. PubMed ID: 27694633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maternal awareness, acceptability and willingness towards respiratory syncytial virus (RSV) vaccination during pregnancy in Ireland.
    McCormack S; Thompson C; Nolan M; Imcha M; Dee A; Saunders J; Philip RK
    Immun Inflamm Dis; 2024 Apr; 12(4):e1257. PubMed ID: 38661110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Respiratory syncytial virus in infants: is maternal vaccination a realistic strategy?
    Munoz FM
    Curr Opin Infect Dis; 2015 Jun; 28(3):221-4. PubMed ID: 25918956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of a respiratory syncytial virus vaccine candidate in a maternal immunization model.
    Blanco JCG; Pletneva LM; McGinnes-Cullen L; Otoa RO; Patel MC; Fernando LR; Boukhvalova MS; Morrison TG
    Nat Commun; 2018 May; 9(1):1904. PubMed ID: 29765035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunopathology of RSV infection: prospects for developing vaccines without this complication.
    van Drunen Littel-van den Hurk S; Mapletoft JW; Arsic N; Kovacs-Nolan J
    Rev Med Virol; 2007; 17(1):5-34. PubMed ID: 17004293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Respiratory syncytial virus vaccine research and development: World Health Organization technological roadmap and preferred product characteristics.
    Vekemans J; Moorthy V; Giersing B; Friede M; Hombach J; Arora N; Modjarrad K; Smith PG; Karron R; Graham B; Kaslow DC
    Vaccine; 2019 Nov; 37(50):7394-7395. PubMed ID: 29395536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alternative Virus-Like Particle-Associated Prefusion F Proteins as Maternal Vaccines for Respiratory Syncytial Virus.
    Blanco JCG; Fernando LR; Zhang W; Kamali A; Boukhvalova MS; McGinnes-Cullen L; Morrison TG
    J Virol; 2019 Dec; 93(23):. PubMed ID: 31511382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influenza and respiratory syncytial virus (RSV) vaccines for infants: safety, immunogenicity, and efficacy.
    Beeler JA; Eichelberger MC
    Microb Pathog; 2013 Feb; 55():9-15. PubMed ID: 23247146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nirsevimab immunization's real-world effectiveness in preventing severe bronchiolitis: A test-negative case-control study.
    Agüera M; Soler-Garcia A; Alejandre C; Moussalam-Merino S; Sala-Castellví P; Pons G; Penela-Sánchez D; González-Grado C; Alsina-Rossell J; Climent C; Esteva C; Fortuny C; de-Sevilla MF; García-García JJ; Brotons P; Balaguer A; Estrada J; Jordan I; Muñoz-Almagro C; Launes C
    Pediatr Allergy Immunol; 2024 Jun; 35(6):e14175. PubMed ID: 38899631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parental knowledge on the respiratory syncytial virus before the nirsevimab immunization program: Attitudes toward immunization in an autonomous community of Spain.
    Zornoza Moreno M; Pérez Martín JJ; Moreno MCG; Abellán MPR
    Hum Vaccin Immunother; 2024 Dec; 20(1):2357439. PubMed ID: 38857859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.